Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Consensus guidelines, algorithms and care of the individual patient with type 2 diabetes.

× No keyword cloud information.

12 in total

Review 1. New drugs for the treatment of diabetes: part II: Incretin-based therapy and beyond.

Authors: Silvio E Inzucchi; Darren K McGuire
Journal: Circulation Date: 2008-01-29 Impact factor: 29.690

2. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors: D M Nathan; J B Buse; M B Davidson; R J Heine; R R Holman; R Sherwin; B Zinman
Journal: Diabetologia Date: 2006-08 Impact factor: 10.122

3. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study.

Authors: Craig J Currie; John R Peters; Aodán Tynan; Marc Evans; Robert J Heine; Oswaldo L Bracco; Tony Zagar; Chris D Poole
Journal: Lancet Date: 2010-01-26 Impact factor: 79.321

4. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.

Authors: C J Currie; C D Poole; E A M Gale
Journal: Diabetologia Date: 2009-07-02 Impact factor: 10.122

5. Important differences: Canadian Diabetes Association 2008 clinical practice guidelines and the consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Authors: V Woo
Journal: Diabetologia Date: 2008-12-24 Impact factor: 10.122

6. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors: D M Nathan; J B Buse; M B Davidson; E Ferrannini; R R Holman; R Sherwin; B Zinman
Journal: Diabetologia Date: 2008-10-22 Impact factor: 10.122

7. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

Authors: Steven E Nissen; Kathy Wolski
Journal: N Engl J Med Date: 2007-05-21 Impact factor: 91.245

8. Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury.

Authors: Leo Timmers; José P S Henriques; Dominique P V de Kleijn; J Hans Devries; Hans Kemperman; Paul Steendijk; Cees W J Verlaan; Marjolein Kerver; Jan J Piek; Pieter A Doevendans; Gerard Pasterkamp; Imo E Hoefer
Journal: J Am Coll Cardiol Date: 2009-02-10 Impact factor: 24.094

9. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus.

Authors: Ralph A Defronzo
Journal: Diabetes Date: 2009-04 Impact factor: 9.461

10. GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice.

Authors: Mohammad Hossein Noyan-Ashraf; M Abdul Momen; Kiwon Ban; Al-Muktafi Sadi; Yu-Qing Zhou; Ali M Riazi; Laurie L Baggio; R Mark Henkelman; Mansoor Husain; Daniel J Drucker
Journal: Diabetes Date: 2009-01-16 Impact factor: 9.461

11 in total

1. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors: S E Inzucchi; R M Bergenstal; J B Buse; M Diamant; E Ferrannini; M Nauck; A L Peters; A Tsapas; R Wender; D R Matthews
Journal: Diabetologia Date: 2012-04-20 Impact factor: 10.122

2. The combinatorics of medications precludes evidence-based algorithms for therapy.

Authors: D Rodbard
Journal: Diabetologia Date: 2010-09-12 Impact factor: 10.122

3. The American Association of Clinical Endocrinologists/American College of Endocrinology (AACE/ACE) algorithm for managing glycaemia in patients with type 2 diabetes mellitus: comparison with the ADA/EASD algorithm.

Authors: H W Rodbard; P S Jellinger
Journal: Diabetologia Date: 2010-09-12 Impact factor: 10.122

4. Should the algorithm for the treatment of type 2 diabetes be evidence-based?

Authors: P-J Guillausseau
Journal: Diabetologia Date: 2010-07-07 Impact factor: 10.122

Review 5. Using insulin in type 2 diabetes: in need of a renaissance?

Authors: David Kerr; Tolulope Olateju
Journal: J Diabetes Sci Technol Date: 2011-07-01

6. From authority recommendations to fact-sheets--a future for guidelines.

Authors: I Mühlhauser
Journal: Diabetologia Date: 2010-08-29 Impact factor: 10.122

Review 7. Stepwise intensification of insulin therapy in type 2 diabetes management--exploring the concept of the basal-plus approach in clinical practice.

Authors: D R Owens
Journal: Diabet Med Date: 2013-03 Impact factor: 4.359

Review 8. Insulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analogues.

Authors: Allan Vaag; Søren S Lund; Sørens Lund
Journal: Eur J Endocrinol Date: 2011-09-19 Impact factor: 6.664

Review 9. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors: Silvio E Inzucchi; Richard M Bergenstal; John B Buse; Michaela Diamant; Ele Ferrannini; Michael Nauck; Anne L Peters; Apostolos Tsapas; Richard Wender; David R Matthews
Journal: Diabetes Care Date: 2012-04-19 Impact factor: 19.112

Review 10. Personalizing guidelines for diabetes management: twilight or dawn of the expert?

Authors: Stavroula A Paschou; Richard David Leslie
Journal: BMC Med Date: 2013-07-10 Impact factor: 8.775